Konstantinos Alataris

Konstantinos Alataris PhD is the co-founder and CEO of Nēsos, a clinical stage company developing disease modifying digital therapeutics targeting the autonomic nervous system’s control of the immune response. Nēsos clinical efforts are in inflammatory mediated diseases with a current focus on autoimmune, neurological and neuropsychiatric disorders. Konstantinos was the founder and CEO of Nevro (NYSE: NVRO). Under his leadership, Nevro advanced Senza®, its implantable neuromodulator therapeutic, from concept to commercialization for neurological disorders. Dr. Alataris received master’s degrees in Electrical Engineering and Business and a Ph.D. in Biomedical Engineering with focus in Computational Neuroscience from the University of Southern California. He received a Bachelor of Science in Electrical and Computer Engineering from the National Technical University of Athens, Greece.